Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.

Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, Fearon P, McGuire PK, Mallett RM, Jones PB, Leff J, Murray RM.

Neuropsychopharmacology. 2005 Apr;30(4):765-74.

2.

Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Navari S, Dazzan P.

Psychol Med. 2009 Nov;39(11):1763-77. doi: 10.1017/S0033291709005315. Epub 2009 Apr 2. Review.

PMID:
19338710
3.

The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?

Borgwardt SJ, Smieskova R, Fusar-Poli P, Bendfeldt K, Riecher-Rössler A.

Psychol Med. 2009 Nov;39(11):1781-2. doi: 10.1017/S0033291709006060. Epub 2009 May 29. No abstract available.

PMID:
19476691
4.

Effects of antipsychotics on brain structure.

Scherk H, Falkai P.

Curr Opin Psychiatry. 2006 Mar;19(2):145-50. Review.

PMID:
16612194
5.

Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.

Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C.

Arch Gen Psychiatry. 2006 Feb;63(2):139-49.

PMID:
16461856
6.

Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss.

Price G, Cercignani M, Chu EM, Barnes TR, Barker GJ, Joyce EM, Ron MA.

Neuroimage. 2010 Jan 1;49(1):185-92. doi: 10.1016/j.neuroimage.2009.07.037. Epub 2009 Jul 23.

7.

The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study.

Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis X, Suckling J, Fearon P, Salvo J, McGuire PK, Mallett RM, Jones PB, Leff J, Murray RM.

Brain. 2004 Jan;127(Pt 1):143-53. Epub 2003 Oct 21.

PMID:
14570821
8.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
9.

Grey matter abnormalities in Brazilians with first-episode psychosis.

Schaufelberger MS, Duran FL, Lappin JM, Scazufca M, Amaro E Jr, Leite CC, de Castro CC, Murray RM, McGuire PK, Menezes PR, Busatto GF.

Br J Psychiatry Suppl. 2007 Dec;51:s117-22. doi: 10.1192/bjp.191.51.s117.

PMID:
18055927
10.

Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.

Tomelleri L, Jogia J, Perlini C, Bellani M, Ferro A, Rambaldelli G, Tansella M, Frangou S, Brambilla P; Neuroimaging Network of the ECNP networks initiative.

Eur Neuropsychopharmacol. 2009 Dec;19(12):835-40. doi: 10.1016/j.euroneuro.2009.07.007. Epub 2009 Aug 29.

PMID:
19717283
11.

Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: a multi-channel near-infrared spectroscopy study.

Chou PH, Koike S, Nishimura Y, Kawasaki S, Satomura Y, Kinoshita A, Takizawa R, Kasai K.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Mar 3;49:63-9. doi: 10.1016/j.pnpbp.2013.11.009. Epub 2013 Nov 22.

PMID:
24275075
12.

[Changes in brain structure caused by neuroleptic medication].

Scherk H, Falkai P.

Nervenarzt. 2004 Nov;75(11):1112-7. Review. German.

PMID:
15365632
13.

The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review.

Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rössler A, Borgwardt SJ.

Curr Pharm Des. 2009;15(22):2535-49. Review.

PMID:
19689326
14.

Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.

McClure RK, Carew K, Greeter S, Maushauer E, Steen G, Weinberger DR.

Schizophr Res. 2008 Jan;98(1-3):29-39. Epub 2007 Oct 31.

PMID:
17976957
15.

Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study.

Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C, Fearon P, Orr K, Hutchinson G, Pantelis C, Velakoulis D, Jones PB, Leff J, Murray RM.

Neuropsychopharmacology. 2005 Oct;30(10):1923-31.

16.

A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.

Lesh TA, Tanase C, Geib BR, Niendam TA, Yoon JH, Minzenberg MJ, Ragland JD, Solomon M, Carter CS.

JAMA Psychiatry. 2015 Mar;72(3):226-34. doi: 10.1001/jamapsychiatry.2014.2178.

17.

Association of grey matter volume deviation with insight impairment in first-episode affective and non-affective psychosis.

McFarland J, Cannon DM, Schmidt H, Ahmed M, Hehir S, Emsell L, Barker G, McCarthy P, Elliott MA, McDonald C.

Eur Arch Psychiatry Clin Neurosci. 2013 Mar;263(2):133-41. doi: 10.1007/s00406-012-0333-8. Epub 2012 Jun 7.

PMID:
22673767
18.

Grey matter abnormalities in first-episode schizophrenia and affective psychosis.

Morgan KD, Dazzan P, Orr KG, Hutchinson G, Chitnis X, Suckling J, Lythgoe D, Pollock SJ, Rossell S, Shapleske J, Fearon P, Morgan C, David A, McGuire PK, Jones PB, Leff J, Murray RM.

Br J Psychiatry Suppl. 2007 Dec;51:s111-6. doi: 10.1192/bjp.191.51.s111.

PMID:
18055926
19.

Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?

Yue Y, Kong L, Wang J, Li C, Tan L, Su H, Xu Y.

PLoS One. 2016 Jan 20;11(1):e0147204. doi: 10.1371/journal.pone.0147204. eCollection 2016.

20.

Improvement of prefrontal brain function in endogenous psychoses under atypical antipsychotic treatment.

Ehlis AC, Herrmann MJ, Pauli P, Stoeber G, Pfuhlmann B, Fallgatter AJ.

Neuropsychopharmacology. 2007 Aug;32(8):1669-77. Epub 2007 Jan 3.

Supplemental Content

Support Center